The Pharmagellan Guide to Biotech Forecasting and Valuation by Frank S. David, Seth Robey, Andrew Matthews
Requirements: .ePUB reader, 3 MB
Overview: If you’re a biotech executive, investor, deal maker, entrepreneur, or adviser—or aspire to be one—then you need to build and analyze forecasts and valuations of R&D-stage drugs. This book is for you.
"Deserves a spot on the bookshelf of every biotech CFO." — Bruce Booth, Partner, Atlas Venture
"A helpful and insightful resource for anyone who finds themselves staring at a blank Excel spreadsheet." — Adam Feuerstein, Senior Columnist, TheStreet.com
"This is the book I wish I’d had when I started out." — Vin Milano, CEO, Idera Pharmaceuticals
"Invaluable, rigorously detailed, and well validated." — John Sullivan, Director of Equity Research, Leerink Partners
The Pharmagellan Guide to Biotech Forecasting and Valuation is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage assets and companies.
Genre: Non-Fiction > General
Download Instructions:
https://ouo.io/Gsh8G1U
https://ouo.io/lEyWRk
